ATE497002T1 - Gef-h1b: biomarker, komplexe, assays und therapeutische verwendungen davon - Google Patents

Gef-h1b: biomarker, komplexe, assays und therapeutische verwendungen davon

Info

Publication number
ATE497002T1
ATE497002T1 AT03763085T AT03763085T ATE497002T1 AT E497002 T1 ATE497002 T1 AT E497002T1 AT 03763085 T AT03763085 T AT 03763085T AT 03763085 T AT03763085 T AT 03763085T AT E497002 T1 ATE497002 T1 AT E497002T1
Authority
AT
Austria
Prior art keywords
gef
biomarrkers
assayes
complexes
therapeutic uses
Prior art date
Application number
AT03763085T
Other languages
English (en)
Inventor
Tod Smeal
Marinella Callow
Bahija Jallal
Sergey Zozulya
Mikhail Gishizky
Original Assignee
Sugen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sugen Inc filed Critical Sugen Inc
Application granted granted Critical
Publication of ATE497002T1 publication Critical patent/ATE497002T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
AT03763085T 2002-07-05 2003-07-02 Gef-h1b: biomarker, komplexe, assays und therapeutische verwendungen davon ATE497002T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39360002P 2002-07-05 2002-07-05
US46005303P 2003-04-04 2003-04-04
PCT/US2003/020743 WO2004005529A2 (en) 2002-07-05 2003-07-02 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF

Publications (1)

Publication Number Publication Date
ATE497002T1 true ATE497002T1 (de) 2011-02-15

Family

ID=30118381

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03763085T ATE497002T1 (de) 2002-07-05 2003-07-02 Gef-h1b: biomarker, komplexe, assays und therapeutische verwendungen davon

Country Status (9)

Country Link
US (3) US7439329B2 (de)
EP (1) EP1539956B1 (de)
JP (1) JP4522855B2 (de)
AT (1) ATE497002T1 (de)
AU (1) AU2003256356A1 (de)
DE (1) DE60335883D1 (de)
DK (1) DK1539956T3 (de)
PT (1) PT1539956E (de)
WO (1) WO2004005529A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861442B1 (en) * 1998-12-30 2005-03-01 Sugen, Inc. PYK2 and inflammation
US20110294782A1 (en) 2006-11-10 2011-12-01 Massachusetts Institute Of Technology Small molecule pak inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939224A (en) * 1987-02-26 1990-07-03 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
DE4412174A1 (de) * 1994-04-08 1995-10-19 Schramm Wolfgang Prof Dr Peptide, Verfahren zu ihrer Herstellung und ihre Verwendung
US5863532A (en) * 1996-03-14 1999-01-26 The Regents Of The University Of California Compositions and methods comprising cytostatic protein kinase
AU3642499A (en) * 1998-04-14 1999-11-01 Sugen, Inc. Ste20-related protein kinases
US6013500A (en) * 1998-05-21 2000-01-11 The Trustees Of Columbia University In The City Of New York PAK4, a novel gene encoding a serine/threonine kinase
CA2387754A1 (en) * 1999-10-29 2001-05-10 Human Genome Sciences, Inc. 10 human secreted proteins
US20050100554A1 (en) * 2002-02-14 2005-05-12 Amanda Jackson Complexes and methods of using same

Also Published As

Publication number Publication date
JP4522855B2 (ja) 2010-08-11
AU2003256356A1 (en) 2004-01-23
US20040091907A1 (en) 2004-05-13
EP1539956B1 (de) 2011-01-26
PT1539956E (pt) 2011-03-16
WO2004005529A3 (en) 2004-07-22
EP1539956A2 (de) 2005-06-15
AU2003256356A8 (en) 2004-01-23
JP2005532062A (ja) 2005-10-27
WO2004005529A2 (en) 2004-01-15
US20090130695A1 (en) 2009-05-21
DE60335883D1 (de) 2011-03-10
EP1539956A4 (de) 2006-09-06
US20110159532A1 (en) 2011-06-30
US7871786B2 (en) 2011-01-18
DK1539956T3 (da) 2011-03-28
US7439329B2 (en) 2008-10-21

Similar Documents

Publication Publication Date Title
BRPI0607306A2 (pt) derivados de quinoxalina como agentes anti-tumor
Moraes et al. Crystal structure of the human ubiquitin conjugating enzyme complex, hMms2–hUbc13
Yang et al. Efficient targeted oncogenic KRASG12C degradation via first reversible-covalent PROTAC
DE602006020544D1 (de) Apolipoprotein-a-ii-isoform als biomarker für prostatakrebs
Schulz-Fincke et al. Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation
ATE438856T1 (de) Biomarker für eierstockkrebs: mit ctap3 verwandte proteine
WO2005084109A3 (en) Cancer specific gene mh15
ATE373239T1 (de) Serum macrophage migration inhibitory factor (mif) als marker für prostata krebs
NO20083153L (no) Kjemiske forbindelser
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
WO2007002069A3 (en) Serum biomarkers for breast cancer
ATE433115T1 (de) Timp-2 als ziel/marker des versagens von beta- zellen
NO20080468L (no) Diazepinokinoliner, synteser av disse samt intermediater
Minor A common variant of the cardiomyopathy associated 5 gene (CMYA5) is associated with schizophrenia in Chinese population
TR200402517T1 (tr) HBV ilaç direnci tespit metotları
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
ATE497002T1 (de) Gef-h1b: biomarker, komplexe, assays und therapeutische verwendungen davon
Elu et al. Identification of substrates for human deubiquitinating enzymes (DUBs): An up-to-date review and a case study for neurodevelopmental disorders
Singasane et al. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with Schiff’s bases incorporating iminoureido moieties
Qureshi et al. New barbiturates and thiobarbiturates as potential enzyme inhibitors
Tu et al. Discovery of lipoic acid-4-phenyl-1 H-pyrazole hybrids as novel bifunctional ROCK inhibitors with antioxidant activity
WO2003104761A3 (en) MEASUREMENT OF MELANOCORTINE PEPTIDES AND USES THEREOF
UA84020C2 (ru) Ингибитор проникновения вируса вил
DE60319989D1 (de) Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande
Godl et al. Proteomic analysis of kinase inhibitor selectivity and function

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1539956

Country of ref document: EP